Evidence map›Paper›PMID 39652357›Full record

ArticleJAMA2025

What to Expect From a Low-Nicotine Product Standard for Cigarettes: A Response to "Denicotinized" Tobacco.

Rachel L Denlinger-Apte, Cassidy M White, Eric C Donny

Abstract read
In one paragraph

Article in JAMA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rachel L Denlinger-ApteDepartment of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Cassidy M WhiteDepartment of Translational Neuroscience, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Eric C DonnyDepartment of Translational Neuroscience, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

Funding

VERY LOW NICOTINE CIGARETTES IN SMOKERS WITH SCHIZOPHRENIAU54DA031659 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HECHT, STEPHEN S · 2011 to 2022
$64.7M
Assessing the real-world impact of a low nicotine product standard for smoked tobacco in New ZealandR01DA058264 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ERIC Christian DONNY, Rachel Denlinger-Apte · 2023 to 2026
$2.6M
The effect of context on the importance of nicotine-content in choices between cigarettes and e-cigarettesR36DA054481 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WHITE, CASSIDY MEGAN · 2021 to 2022
$107k
NIDA NIH HHS R01 DA058264NIDA NIH HHS R36 DA054481NIDA NIH HHS U54 DA031659
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39652357
PMCPMC12235553

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.